“Years later, this breakthrough would be the key to delivering Moderna’s mRNA vaccine into the targeted cells that would trigger an immune response in the body.” – Northwestern complaint ...

The Taliban has ordered media in three provinces of Afghanistan to stop airing images of any living being, a drastic step widely criticized by journalism and civil liberty groups. A Taliban ...

Moderna earned $5.4 billion in U.S. revenues in 2021 and $4.4 billion in 2022 from COVID-19 vaccine sales. Northwestern University’s nanotechnology research institute, IIN, has supported over $2 ...

The image is part of a study that shows how neurons respond to deficiencies in their actin cytoskeletons, which controls the cells' shape and structure. This response may play a role in ...

The case underscores ongoing disputes over patent royalties in the pharmaceutical industry. This image is AI-generated and does not depict any real-life event or location. It is a fictional ...

British drugmaker GlaxoSmithKline sued Moderna in US federal court in Delaware on Tuesday (Oct 15), accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

GSK previously sued Pfizer and BioNTech over similar claims concerning their COVID-19 vaccines. This image is AI-generated and does not depict any real-life event or location. It is a fictional ...

On Windows 11 (and 10), the Photos app is the default experience for organizing and editing your pictures, but if it's causing problems, you have a few ways to resolve them, and in this guide ...

COVID and flu season is coming sooner than you might think, and getting up to date with vaccines is the best way to protect yourself in the months ahead. This year’s COVID vaccine is a little ...

Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells. Columbia researchers have engineered ...

British drugmaker GlaxoSmithKline sued Moderna in US federal court in Delaware on Tuesday, accusing its American rival of violating GSK's patent rights in messenger RNA (mRNA) technology with its ...

The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and respiratory syncytial virus shot mResvia. The lawsuits, filed separately in the U.S.